Occam Places Gurpreet Ratra as CBO at Skyline
Skyline Therapeutics, an F-Prime/Eight Roads investment, is a cell & gene therapy company developing novel genetic medicines across multiple therapeutic areas for global markets. The company has extensive R&D and manufacturing operations in Shanghai and affiliate offices in the U.S.
In August 2020, Occam recruited Gurpreet Ratra, PhD as the company’s CBO. Prior to joining Skyline, Gurpreet served as Head of Business Development at Spark Therapeutics.
Recent Placements
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.